Organon Valuation
| 7XP Stock | 6.18 0.01 0.16% |
At this time, the company appears to be overvalued. Organon holds a recent Real Value of USD5.56 per share. The prevailing price of the company is USD6.18. Our model determines the value of Organon from analyzing the company fundamentals such as Operating Margin of 0.16 %, shares outstanding of 259.98 M, and Return On Equity of 0.27 as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.1093 | Enterprise Value 8.5 B | Enterprise Value Ebitda 10.8474 | Price Sales 0.2585 | Forward PE 5.0201 |
Overvalued
Today
Please note that Organon's price fluctuation is slightly risky at this time. Calculation of the real value of Organon is based on 3 months time horizon. Increasing Organon's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Organon stock is determined by what a typical buyer is willing to pay for full or partial control of Organon Co. Since Organon is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Organon Stock. However, Organon's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.18 | Real 5.56 | Hype 6.18 |
The real value of Organon Stock, also known as its intrinsic value, is the underlying worth of Organon Company, which is reflected in its stock price. It is based on Organon's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Organon's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Organon Co helps investors to forecast how Organon stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Organon more accurately as focusing exclusively on Organon's fundamentals will not take into account other important factors: Organon Cash |
|
Organon Total Value Analysis
Organon Co is presently estimated to have takeover price of 8.49 B with market capitalization of 1.61 B, debt of 20 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Organon fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.49 B | 1.61 B | 20 M |
Organon Investor Information
About 76.0% of the company shares are owned by institutions such as pension funds. The book value of Organon was presently reported as 2.94. The company last dividend was issued on the 23rd of February 2026. Based on the analysis of Organon's profitability, liquidity, and operating efficiency, Organon Co is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 802.8 M | 845.1 M |
|
| |||||
| Operating Income | 1.8 B | 1.3 B |
|
|
Organon Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Organon has an asset utilization ratio of 48.87 percent. This implies that the Company is making USD0.49 for each dollar of assets. An increasing asset utilization means that Organon Co is more efficient with each dollar of assets it utilizes for everyday operations.Organon Profitability Analysis
Considering Organon's profitability and operating efficiency indicators, Organon Co may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Organon's ability to earn profits and add value for shareholders.Net Income | First Reported 2020-03-31 | Previous Quarter 145 M | Current Value 160 M | Quarterly Volatility 172.8 M |
For Organon profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Organon to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Organon utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Organon's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Organon over time as well as its relative position and ranking within its peers.
Organon Earnings per Share Projection vs Actual
By analyzing Organon's earnings estimates, investors can diagnose different trends across Organon's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Organon Co is based on EPS before non-recurring items and includes expenses related to employee stock options.Organon Ownership Allocation
Organon owns a total of 259.98 Million outstanding shares. The majority of Organon Co outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Organon to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Organon. Please pay attention to any change in the institutional holdings of Organon as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Organon Profitability Analysis
The company reported the revenue of 6.4 B. Net Income was 864 M with profit before overhead, payroll, taxes, and interest of 3.36 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Organon's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Organon and how it compares across the competition.
About Organon Valuation
The stock valuation mechanism determines Organon's current worth on a weekly basis. Our valuation model uses a comparative analysis of Organon. We calculate exposure to Organon's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Organon's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.3 B | 3.5 B |
Complementary Tools for Organon Stock analysis
When running Organon's price analysis, check to measure Organon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organon is operating at the current time. Most of Organon's value examination focuses on studying past and present price action to predict the probability of Organon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organon's price. Additionally, you may evaluate how the addition of Organon to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |